Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
Leandro César Mendes, Raquel SB Stucchi, Aline G Vigani Department of Infectious Diseases, State University of Campinas, Campinas, SP, Brazil Abstract: In the past years, what has always been considered undisputed true in liver fibrosis staging has been challenged. Diagnostic performance...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8feab77c7a024ef18c1ee775ab706ce0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8feab77c7a024ef18c1ee775ab706ce0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8feab77c7a024ef18c1ee775ab706ce02021-12-02T02:17:14ZDiagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies1179-1535https://doaj.org/article/8feab77c7a024ef18c1ee775ab706ce02018-04-01T00:00:00Zhttps://www.dovepress.com/diagnosis-and-staging-of-fibrosis-in-patients-with-chronic-hepatitis-c-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Leandro César Mendes, Raquel SB Stucchi, Aline G Vigani Department of Infectious Diseases, State University of Campinas, Campinas, SP, Brazil Abstract: In the past years, what has always been considered undisputed true in liver fibrosis staging has been challenged. Diagnostic performance of histological evaluation has proven to be significantly influenced by sample- and observer-related variabilities. Differentiation between lower levels of fibrosis remains difficult for many, if not all, test modalities, including liver biopsy but, perhaps, such a distinction is not indispensable in light of current therapeutic approaches. Biomarkers and elastography offer, nonetheless, high predictive values for advanced fibrosis and cirrhosis and correlate well with liver-related outcomes. Necroinflammation, steatosis, and hemodynamic changes may significantly interfere with elastography-based techniques, and longitudinal follow-up strategies must be tailored in light of these findings. Knowledge of different test modalities and diagnostic performance indicators can allow for better clinical decision-making and resource allocation. Keywords: chronic hepatitis C, fibrosis, staging, elastography, biomarkersMendes LCStucchi RSBVigani AGDove Medical Pressarticlechronic hepatitis CfibrosisstagingelastographybiomarkersDiseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol Volume 10, Pp 13-22 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
chronic hepatitis C fibrosis staging elastography biomarkers Diseases of the digestive system. Gastroenterology RC799-869 |
spellingShingle |
chronic hepatitis C fibrosis staging elastography biomarkers Diseases of the digestive system. Gastroenterology RC799-869 Mendes LC Stucchi RSB Vigani AG Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies |
description |
Leandro César Mendes, Raquel SB Stucchi, Aline G Vigani Department of Infectious Diseases, State University of Campinas, Campinas, SP, Brazil Abstract: In the past years, what has always been considered undisputed true in liver fibrosis staging has been challenged. Diagnostic performance of histological evaluation has proven to be significantly influenced by sample- and observer-related variabilities. Differentiation between lower levels of fibrosis remains difficult for many, if not all, test modalities, including liver biopsy but, perhaps, such a distinction is not indispensable in light of current therapeutic approaches. Biomarkers and elastography offer, nonetheless, high predictive values for advanced fibrosis and cirrhosis and correlate well with liver-related outcomes. Necroinflammation, steatosis, and hemodynamic changes may significantly interfere with elastography-based techniques, and longitudinal follow-up strategies must be tailored in light of these findings. Knowledge of different test modalities and diagnostic performance indicators can allow for better clinical decision-making and resource allocation. Keywords: chronic hepatitis C, fibrosis, staging, elastography, biomarkers |
format |
article |
author |
Mendes LC Stucchi RSB Vigani AG |
author_facet |
Mendes LC Stucchi RSB Vigani AG |
author_sort |
Mendes LC |
title |
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies |
title_short |
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies |
title_full |
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies |
title_fullStr |
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies |
title_full_unstemmed |
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies |
title_sort |
diagnosis and staging of fibrosis in patients with chronic hepatitis c: comparison and critical overview of current strategies |
publisher |
Dove Medical Press |
publishDate |
2018 |
url |
https://doaj.org/article/8feab77c7a024ef18c1ee775ab706ce0 |
work_keys_str_mv |
AT mendeslc diagnosisandstagingoffibrosisinpatientswithchronichepatitisccomparisonandcriticaloverviewofcurrentstrategies AT stucchirsb diagnosisandstagingoffibrosisinpatientswithchronichepatitisccomparisonandcriticaloverviewofcurrentstrategies AT viganiag diagnosisandstagingoffibrosisinpatientswithchronichepatitisccomparisonandcriticaloverviewofcurrentstrategies |
_version_ |
1718402609375608832 |